Skip to main content
fghjkjhb

Evidence gap analysis

Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The DRG tariffs for 2025 released in Denmark

On November 12, 2024, the Danish Health Data Authority (Sundhedsdatastyrelsen) published the DRG tariffs, as well as psychiatric and rehabilitation rates for 2025. 

In accordance with the released documentation, four new DRGs in the fields of radiology, dermatology, and the treatment of functional disorders will be introduced in 2025.

The DRG tariff system guide (Takstsystem), which provides an overall description of billing rules, tariffs, and grouping logic (including the changes to be introduced in 2025), is not yet available and is expected to be published later.

See the full details in Danish here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.